Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Internet Device Promotion Policies Still Evolving, PAPS Staffer Wolf Tells FDLI

This article was originally published in The Gray Sheet

Executive Summary

Password protection on an Internet web site is an acceptable technique to limit viewing audience, but it should not be used in lieu of compliance with content requirements, CDRH officials warn.

You may also be interested in...



FDA’s Deborah Wolf

Office of Ombudsman detail as regulatory counsel is expected to extend into March. Wolf, who recently returned from a Congressional fellowship through the American Political Science Association, previously served as acting director of the CDRH promotion and advertising policy staff (1"The Gray Sheet" Oct. 22, 2001, p. 10)...

FDA’s Deborah Wolf

Office of Ombudsman detail as regulatory counsel is expected to extend into March. Wolf, who recently returned from a Congressional fellowship through the American Political Science Association, previously served as acting director of the CDRH promotion and advertising policy staff (1"The Gray Sheet" Oct. 22, 2001, p. 10)...

FDA Opens Floor For Debate Of Off-Label Claims, First Amendment Issues

FDA's request for comments on First Amendment issues creates a forum for stakeholders to submit comments on FDA's policy regarding off-label claims

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel